Target Name: MAN1B1-DT
NCBI ID: G100289341
Review Report on MAN1B1-DT Target / Biomarker Content of Review Report on MAN1B1-DT Target / Biomarker
Other Name(s): MAN1B1 divergent transcript | MAN1B1-AS1

MAN1B1-DT: A Potential Drug Target and Biomarker

Man1B1-DT, also known as man1b1-DNA, is a protein that is expressed in the brain and is associated with the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. The protein is a key component of the huntingtin gene family, which is known for its involvement in various neurological disorders.

One of the main challenges in the treatment of neurodegenerative diseases is the development of resistance to drugs and the development of new drug targets. MAN1B1-DT is a potential drug target because it is involved in the development and progression of these diseases and can be targeted with small molecules or antibodies.

Research has shown that MAN1B1-DT is involved in the formation of neurofibrillary tangles, which are a hallmark of neurodegenerative diseases. These tangles are composed of abnormal aggregates of the protein tau and beta-amyloid, which are thought to contribute to the development and progression of these diseases.

In addition, MAN1B1-DT has been shown to be involved in the regulation of the neurotransmitter glutamate, which is a key signaling molecule in the brain. This suggests that it may be involved in the pathophysiology of neurodegenerative diseases.

MAN1B1-DT is also a potential biomarker for the early detection of neurodegenerative diseases. The protein is expressed in the brain and can be used as a protein biomarker for the diagnosis and monitoring of these diseases. This has the potential to revolutionize the field of neurodegenerative disease research and treatment.

In conclusion, MAN1B1-DT is a potential drug target and biomarker for the treatment of neurodegenerative diseases. Further research is needed to fully understand its role in the development and progression of these diseases and to develop effective treatments.

Protein Name: MAN1B1 Divergent Transcript

The "MAN1B1-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAN1B1-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at

More Common Targets

MAN1C1 | MAN2A1 | MAN2A2 | MAN2B1 | MAN2B2 | MAN2C1 | MANBA | MANBAL | MANCR | MANEA | MANEA-DT | MANEAL | MANF | MANSC1 | MANSC4 | MAOA | MAOB | MAP10 | MAP1A | MAP1B | MAP1LC3A | MAP1LC3B | MAP1LC3B2 | MAP1LC3BP1 | MAP1LC3C | MAP1S | MAP2 | MAP2K1 | MAP2K1P1 | MAP2K2 | MAP2K3 | MAP2K4 | MAP2K4P1 | MAP2K5 | MAP2K6 | MAP2K7 | MAP3K1 | MAP3K10 | MAP3K11 | MAP3K12 | MAP3K13 | MAP3K14 | MAP3K14-AS1 | MAP3K15 | MAP3K19 | MAP3K2 | MAP3K2-DT | MAP3K20 | MAP3K20-AS1 | MAP3K21 | MAP3K3 | MAP3K4 | MAP3K5 | MAP3K5-AS2 | MAP3K6 | MAP3K7 | MAP3K7CL | MAP3K8 | MAP3K9 | MAP3K9-DT | MAP4 | MAP4K1 | MAP4K1-AS1 | MAP4K2 | MAP4K3 | MAP4K3-DT | MAP4K4 | MAP4K5 | MAP6 | MAP6D1 | MAP7 | MAP7D1 | MAP7D2 | MAP7D3 | MAP9 | MAPK1 | MAPK10 | MAPK10-AS1 | MAPK11 | MAPK12 | MAPK13 | MAPK14 | MAPK15 | MAPK1IP1L | MAPK3 | MAPK4 | MAPK6 | MAPK6P2 | MAPK7 | MAPK8 | MAPK8IP1 | MAPK8IP1P2 | MAPK8IP2 | MAPK8IP3 | MAPK9 | MAPKAP1 | MAPKAPK2 | MAPKAPK3 | MAPKAPK5 | MAPKAPK5-AS1